what is the icd 10 code for etoposide

What is the CPT code for etoposide 10 mg?

J9181 is a valid 2019 HCPCS code for Injection, etoposide, 10 mg or just “Etoposide injection” for short, used in Medical care. J9181 has been in effect since 01/01/2009. Long description: Injection, etoposide, 10 mg.

How does etoposide work?

Etoposide works by slowing the growth of cancer cells. Etoposide with NDC 63323-104 is a a human prescription drug product labeled by Fresenius Kabi Usa, Llc. The generic name of Etoposide is etoposide. The product's dosage form is injection, solution and is administered via intravenous form.

What are the possible adverse effects of etoposide?

Hepatic toxicity, generally in patients receiving higher doses of the drug than those recommended, has been reported with etoposide. Metabolic acidosis has also been reported in patients receiving higher doses. Reports of extravasation with swelling have been received postmarketing.

What is the ICD 10 code for diagnosis 2022?

2022 ICD-10-CM Diagnosis Code R04.0 R04.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM R04.0 became effective on October 1, 2021.

What is the J code for etoposide?

HCPCS code J9181 for Injection, etoposide, 10 mg as maintained by CMS falls under Chemotherapy Drugs.

What is the ICD-10 code for current chemotherapy treatment?

1 for Encounter for antineoplastic chemotherapy and immunotherapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .

What is the ICD-10 code for pre chemotherapy?

Report ICD-10 code Z01. 818, Encounter for other preprocedural examination (is defined as Encounter for preprocedural examination NOS and Encounter for examinations prior to antineoplastic chemotherapy), when the test is performed as a baseline study before chemotherapy. List Z01. 818 as your primary diagnosis code.

What is the ICD-10 code for Adverse effect of chemotherapy?

ICD-10-CM Code for Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter T45. 1X5A.

What is the ICD-10 PCS code for chemotherapy?

2022 ICD-10-PCS Procedure Code 3E03305: Introduction of Other Antineoplastic into Peripheral Vein, Percutaneous Approach.

Is antineoplastic the same as chemotherapy?

Antineoplastic drugs are medications used to treat cancer. Other names for antineoplastic drugs are anticancer, chemotherapy, chemo, cytotoxic, or hazardous drugs.

How do you code chemotherapy?

Code 96413 (chemotherapy administration, intravenous infusion technique; up to one hour, single or initial substance/drug) would be used to report the first 90 minutes of the infusion.

How do you bill for chemo?

Office visits on the day of chemo should be reported using the appropriate E/M code (usually 99214-99215) with modifier -24 if during the global period.

Which of the following codes would be used when a patient presents for antineoplastic chemotherapy?

11, Encounter for antineoplastic chemotherapy; or Z51.

What is the ICD-10 code for immunosuppressed due to chemotherapy?

ICD-10 Code ICD-10 Description Assign when immunodeficiency is due to: D84. 821 Immunodeficiency due to drugs Medications that interfere with the immune system. These medications include immunosuppressants, corticosteroids, and chemotherapy.

What is antineoplastic chemotherapy induced pancytopenia?

810 for Antineoplastic chemotherapy induced pancytopenia is a medical classification as listed by WHO under the range - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism .

What is Adverse effect of antineoplastic and immunosuppressive drugs?

1X5 for Adverse effect of antineoplastic and immunosuppressive drugs is a medical classification as listed by WHO under the range - Injury, poisoning and certain other consequences of external causes .

What is etoposide injection?

Etoposide Injection, USP in combination therapy with other approved chemotherapeutic agents in patients with refractory testicular tumors who have already received appropriate surgical, chemotherapeutic, and radiotherapeutic therapy.Adequate data on the use of etoposide capsules in the treatment of testicular cancer are not available.

What are the reactions to etoposide?

Anaphylactic-like reactions characterized by chills, fever, tachycardia, bronchospasm, dyspnea, and/or hypotension have been reported to occur in 0.7% to 2% of patients receiving intravenous etoposide and in less than 1% of the patients treated with the oral capsules. These reactions have usually responded promptly to the cessation of the infusion and administration of pressor agents, corticosteroids, antihistamines, or volume expanders as appropriate; however, the reactions can be fatal. Hypertension and/or flushing have also been reported. Blood pressure usually normalizes within a few hours after cessation of the infusion. Anaphylactic-like reactions have occurred during the initial infusion of etoposide. Facial/tongue swelling, coughing, diaphoresis, cyanosis, tightness in throat, laryngospasm, back pain, and/or loss of consciousness have sometimes occurred in association with the above reactions. In addition, an apparent hypersensitivity-associated apnea has been reported rarely. Rash, urticaria, and/or pruritus have infrequently been reported at recommended doses. At investigational doses, a generalized pruritic erythematous maculopapular rash, consistent with perivasculitis, has been reported.

How long is etoposide stable?

Unopened vials of Etoposide Injection, USP are stable for 24 months at room temperature (25°C). Vials diluted as recommended to a concentration of 0.2 to 0.4 mg/mL are stable for 96 and 24 hours, respectively, at room temperature (25°C) under normal room fluorescent light in both glass and plastic containers. Procedures for proper handling and disposal of anticancer drugs should be considered. Several guidelines on this subject have been published.1-8 There is no general agreement that all of the procedures recommended in the guidelines are necessary or appropriate.

How long to administer etoposide?

Hypotension following rapid intravenous administration has been reported, hence, it is recommended that the etoposide solution be administered over a 30- to 60-minute period. A longer duration of administration may be used if the volume of fluid to be infused is a concern. Etoposide should not be given by rapid intravenous injection. Parenteral drug products should be inspected visually for particulate matter and discoloration (see DESCRIPTION) prior to administration whenever solution and container permit.

When should you do a complete blood count for etoposide?

Periodic complete blood counts should be done during the course of etoposide treatment. They should be performed prior to each cycle of therapy and at appropriate intervals during and after therapy. At least one determination should be done prior to each dose of etoposide.

Can etoposide be excreted in milk?

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from etoposide, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Is etoposide mutagenic?

Etoposide has been shown to be mutagenic in Ames assay. Treatment of Swiss-Albino mice with 1.5 mg/kg I.P. of etoposide on day 7 of gestation increased the incidence of intrauterine death and fetal malformations as well as significantly decreased the average fetal body weight. Maternal weight gain was not affected. Irreversible testicular atrophy was present in rats treated with etoposide intravenously for 30 days at 0.5 mg/kg/day (about 1/16th of the human dose on a mg/m2 basis).Pregnancy: Pregnancy Category D.See WARNINGS.

What is the 2021 HCPCS code for etoposide?

J9181 is a valid 2021 HCPCS code for Injection, etoposide, 10 mg or just “ Etoposide injection ” for short, used in Medical care .

What is BETOS code?

A code denoting Medicare coverage status. The Berenson-Eggers Type of Service (BETOS) for the procedure code based on generally agreed upon clinically meaningful groupings of procedures and services. A code denoting the change made to a procedure or modifier code within the HCPCS system.